1378029-49-2 Usage
General Description
(3S,4R)-1-benzyl-3-(2-chloroethyl)-4-phenylazetidin-2-one is a chemical compound that belongs to the family of azetidin-2-one compounds. It has a molecular formula of C19H21ClNO and a molecular weight of 313.83 g/mol. (3S,4R)-1-benzyl-3-(2-chloroethyl)-4-phenylazetidin-2-one is a chiral molecule with a specific stereochemistry denoted by the (3S,4R) configuration. It contains a benzyl group, a 2-chloroethyl group, and a phenyl group attached to the azetidin-2-one ring. (3S,4R)-1-benzyl-3-(2-chloroethyl)-4-phenylazetidin-2-one is commonly used in medicinal chemistry and pharmaceutical research, with potential applications in the development of new drugs and medications. Its specific chemical structure and properties make it an interesting target for further study and exploration in the field of organic chemistry and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 1378029-49-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,8,0,2 and 9 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1378029-49:
(9*1)+(8*3)+(7*7)+(6*8)+(5*0)+(4*2)+(3*9)+(2*4)+(1*9)=182
182 % 10 = 2
So 1378029-49-2 is a valid CAS Registry Number.
1378029-49-2Relevant articles and documents
Design, synthesis, and antiviral evaluation of purine-β-lactam and purine-aminopropanol hybrids
D'Hooghe, Matthias,Mollet, Karen,De Vreese, Rob,Jonckers, Tim H. M.,Dams, Géry,De Kimpe, Norbert
experimental part, p. 5637 - 5641 (2012/08/29)
Purine-β-lactam chimera were prepared as a novel class of hybrid systems through N-alkylation of 6-benzylamino- or 6-benzyloxypurine with (ω-haloalkyl)-β-lactams, followed by reductive ring opening of the β-lactam ring by LiEt3BH to provide an entry into the class of purine-aminopropanol hybrids. Both new types of hybrid systems were assessed for their antiviral activity and cytotoxicity, resulting in the identification of eight purine-β-lactam hybrids and two purine-aminopropanol hybrids as promising lead structures.
